Source: Annual Congress 2010 - Exercise training and pulmonary rehabilitation
Disease area: Airway diseases

Abstract

Rationale: There are no clear guidelines regarding arm training for patients with COPD. The objective of this study was to evaluate the effect of upper extremity resistance training for patients with COPD on arm function, arm exercise capacity, muscle strength, dyspnea during activity of daily living (ADL) and health related quality of life (HRQL). Methods: Patients were randomly assigned to an intervention or control group. The intervention group underwent upper extremity resistance training while the control group performed a sham. Both groups exercised 3 times a week for 6 weeks. Arm function and exercise capacity were measured using the 6-minute pegboard and ring test (6PBRT) and the unsupported upper limb exercise test (UULEX), respectively. Muscle strength for the biceps, triceps, anterior and middle deltoids was obtained using an isometric dynamometer. Dyspnea during ADL and HRQL were measured using the chronic respiratory disease questionnaire (CRDQ). Results: Thirty–six patients with moderate to severe COPD (66 ± 9 yrs) participated in the study. Compared with the control group, the magnitude of change in the intervention group was greater for the 6PBRT (p = 0.032), UULEX (p = 0.009) and elbow flexion force (p = 0.010); elbow extension force (p = 0.025), shoulder flexion force (p = 0.029) and shoulder abduction force (p = 0.006). There was no difference between groups in dyspnea during ADL, HRQL or symptoms during the 6PBRT or UULEX. Conclusions: Resistance based arm training improved arm function, arm exercise capacity and muscle strength in patients with COPD. Our results can be used to guide clinical practice pertaining to upper extremity training in individuals with COPD.

Rating:

Share or cite this content

Citations should be made in the following way:
T. Janaudis-Ferreira, K. Hill, R. Goldstein, P. Robles-Ribeiro, M. Beauchamp, T. Dolmage, K. Wadell, D. Brooks (Toronto, Canada; Umeå, Sweden). Resistance arm training in patients with COPD: A randomized controlled trial. Eur Respir J 2010; 36: Suppl. 54, 1936

Member's Comments

No comment yet.

Related content which might interest you: Effect of ADL- training for persons with COPD: A randomized controlled trial Source: Annual Congress 2011 - Pulmonary rehabilitation: looking at alternative approaches and alternative populations beyond COPD Year: 2011 Diaphragmatic breathing training in COPD patients: A randomized, controlled and blinded trial Source: Annual Congress 2010 - Respiratory muscles and breathing: assessment and training Year: 2010 Effectiveness of an intervention of Urban Training in patients with COPD: a randomized controlled trial Source: International Congress 2017 – The importance of physical activity in patients with COPD Year: 2017 A self-management programme for COPD: a randomised controlled trial Source: Eur Respir J 2014; 44: 1538-1547 Year: 2014 Working memory training efficacy in COPD: the randomised, double-blind, placebo-controlled Cogtrain trial Source: ERJ Open Res, 7 (4) 00475-2021; 10.1183/23120541.00475-2021 Year: 2021 Effects of downhill walking in pulmonary rehabilitation for patients with COPD: a randomised controlled trial Source: Eur Respir J, 56 (3) 2000639; 10.1183/13993003.00639-2020 Year: 2020 Outpatient vs. home-based pulmonary rehabilitation in COPD: A randomized controlled trial Source: Annual Congress 2011 - Pulmonary rehabilitation: looking at alternative approaches and alternative populations beyond COPD Year: 2011 Regular exercise and asthma control in adults: A randomized controlled trial Source: International Congress 2017 – Techniques to treat asthma Year: 2017 Maintenance of exercise capacity following pulmonary rehabilitation in COPD: randomised controlled trial Source: Annual Congress 2009 - Improving outcome through exercise training or physiotherapy interventions Year: 2009 Effects of respiratory muscle training with different modalities in COPD patients: A randomized controlled trial Source: International Congress 2019 – Assessment and training of respiratory muscles Year: 2019 Azithromycin for treatment of hospitalised COVID-19 patients: a randomised, multicentre, open-label clinical trial (DAWn-AZITHRO) Source: ERJ Open Res, 8 (1) 00610-2021; 10.1183/23120541.00610-2021 Year: 2022 A double-blind randomised controlled trial of protein supplementation to enhance exercise capacity in COPD during pulmonary rehabilitation: a pilot study Source: ERJ Open Res, 7 (1) 00077-2021; 10.1183/23120541.00077-2021 Year: 2021 Late Breaking Abstract - A randomised, double-blind, placebo controlled, clinical trial evaluating imatinib in patients with severe COVID-19 Source: Virtual Congress 2021 – Late breaking basic and translational science of SARS-Cov2 and COVID-19 Year: 2021 Long term azithromycin treatment: A randomised placebo-controlled trial in non-CF bronchiectasis; results from the BAT trial Source: Annual Congress 2011 - Advances in antibiotic therapy of non-cystic fibrosis bronchiectasis Year: 2011 A phase III randomised controlled trial of single-dose triple therapy in COPD: the IMPACT protocol Source: Eur Respir J 2016; 48: 320-330 Year: 2016 Breathing exercises for specialist care asthma patients: a multicentre randomised trial Source: Virtual Congress 2021 – ALERT: Asthma in adult, in children and ILDs Year: 2021 The nutritional enhancement of exercise training in COPD. A randomised, controlled trial Source: Eur Respir J 2002; 20: Suppl. 38, 262s Year: 2002 Home-based pulmonary rehabilitation in patients with bronchiectasis: a randomized controlled trial Source: International Congress 2017 – New trends in pulmonary rehabilitation and chronic care Year: 2017 Acute effects of nasal high-flow during exercise in COPD patients after an exacerbation : a randomized controlled cross-over trial Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019 ß-blockers in exacerbations of COPD: feasibility of a randomised controlled trial Source: ERJ Open Res, 3 (1) 00090-2016; 10.1183/23120541.00090-2016 Year: 2017